Navigation Links
New Book Looks at Clinical Research from the Patient's Point of View
Date:12/19/2007

DEDHAM, Mass., Dec. 19 /PRNewswire/ -- Clinical research volunteer John Cleland has run four marathons, but the race he is proudest to have won was against testicular cancer. Diagnosed with the disease as a college undergraduate, Cleland underwent surgical removal of his testicle and 53 lymph nodes. Three punishing rounds of chemotherapy followed. But when Cleland's cancer spread to his lungs, the 22-year-old's chances for survival looked slim.

Then Cleland's doctor offered one small ray of hope. A clinical trial of a new chemotherapy was beginning and Cleland could be one of the first people to enroll in it. Faced with near certain death and no other viable treatment options, Cleland chose to join the trial.

That was in 1973, and today Cleland, 56, has been cancer free for more than 30 years. The experimental drug he tested has been successfully used on thousands of patients, Tour-de-France winner Lance Armstrong among them, and clinical trials have become the standard launching pad for a growing array of medical advances.

It is for the more than 2 million Americans who participate in clinical research each year that the new book, The Gift of Participation: A Guide to Making Informed Decisions about Volunteering for a Clinical Trial, was published in September. Written by Kenneth Getz, founder and Board Chair of the Center for Information and Study on Clinical Research Participation (CISCRP), the 360-page volume examines clinical research from the volunteer's perspective and answers important questions about this frequently misunderstood field, such as: why clinical trials are conducted; why human subjects are needed; the meaning of informed consent; and how clinical research participants are protected. Practical advice on subjects like insurance coverage, compensation, and tax ramifications for clinical research volunteers also is included.

Getz, who founded the online publisher, Centerwatch, and co-authored the previous book, Informed Consent: A Guide to the Risks and Benefits of Volunteering for Clinical Trials, with Deborah Borfitz in 2002, says the new book expands on his earlier effort.

"After the first book was published, I realized certain pieces were missing that I felt were critical," Getz explains. In an effort to fill the gaps, Getz's new book looks at why clinical research participation matters and explains the important role it plays in furthering medical knowledge. Real-life stories from clinical trial volunteers about their own experiences reveal the human side of clinical research. With a foreword written by Congressman Rick Boucher (D-VA) and a back cover endorsement from Armstrong, The Gift of Participation provides a detailed road map into a complex world many readers will be eager to explore.

Proceeds from the book's sale will be used to help fund CISCRP's efforts on behalf of public education about clinical research. As the public's thirst for new therapies and treatments expands, Getz expects the need for information will grow. That's where he hopes The Gift of Participation will have its greatest impact.

"Ideally, I would like to see the lay public and prospective participants get the book and use it as a guide to learn about and make choices about clinical research," he relates. "I'd be really happy to know that people are using it as one of many inputs in their decision-making about clinical research participation."

The Gift of Participation: A Guide to Making Informed Decisions about Volunteering for a Clinical Trial can be purchased through the CISCRP Online Bookstore or by phone. Copies also may be obtained at major online and retail booksellers. For more information or to purchase a copy, go to http://www.ciscrp.org/e-store/store.asp or phone at 1-888-CISCRP3.

Contact:

Karyl Weicher

781-326-3400 (CISCRP office)

karylweicher@ciscrp.org

OR

Melody Howard Ritt

781-784-5790 (W)


'/>"/>
SOURCE CISCRP
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. IMPACT initiative looks to improve patient participation in clinical trials
2. Test for lung cancer looks for discomforting quiet among protective genes
3. Study looks at mitochondrial variation in sperm traits and sperm competitive ability
4. Experts Agree. Ohios Technology Investment Future Looks Bright
5. Radiologists encouraged to look beyond cancer for clinically unseen diseases
6. Clinical depression linked to abnormal emotional brain circuits
7. Preclinical study suggests organ-transplant drug may aid in lupus fight
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Good Clinical Practice Journal Awards: Winners Announced
10. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
11. Study Questions Dead-End Cancer Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... franchises from across the country gathered at the La Valencia Hotel in San ... PROSHRED Chicago was named the year’s most outstanding franchise, walking away with ...
(Date:2/5/2016)... ... 05, 2016 , ... Pivot Point Consulting, a leading national ... & Services for HIT Implementation Support & Staffing report with an outstanding score ... by healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Colorize ... from on one drop zone to the next using Colorize's dynamic moving camera. Colorize ... project. This package includes a 3D slideshow environment with 1 to 5 focus points ...
(Date:2/5/2016)... ... 05, 2016 , ... Calls Blacklist has just been updated by mobile app ... the developer has fixed known bugs within the app. Calls Blacklist allows its users ... not consuming any of their device’s battery power or memory. It provides a powerful ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... has entered into a settlement agreement with the ... resolving the SEC,s investigation into possible violations of ... terms of the settlement agreement, SciClone has agreed ... disgorgement, pre-judgment interest and a penalty.  This payment ...
(Date:2/4/2016)... -- Global Immunology Market to 2022 - Large ... growth Summary Immune-mediated inflammatory diseases are ... affect 5–7% of western populations. Although they are ... key patient demographics, they are pathophysiologically linked, being ... inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, a ...
(Date:2/4/2016)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... treat life-threatening diseases, today announced results for the ... 2015. --> --> ... our last quarterly call, we strategically advanced pre-clinical ... to establish the Aethlon Hemopurifier® as a leading ...
Breaking Medicine Technology: